“Crisaptics Trans-BBB” Team Among NIH TARGETED Challenge Winners

Congratulations to the “Crisaptics Trans-BBB” Genome Editing Team (Drs. Poulopoulos, Suk, Woodworth, and Anastasiadis), selected as one of four winners in the NIH TARGETED Challenge focused on genome editor delivery in the brain. The team received a $250,000 award and has been invited to compete in Phase 3 of the challenge.